KSHV infection drives poorly cytotoxic CD56-negative natural killer cell differentiation in vivo upon KSHV/EBV dual infection

Autor: Peter O Oluoch, Ann M. Moormann, Lara Zuppiger, Nicole Caduff, Thomas F. Schulz, David J. Blackbourn, Lisa Rieble, Christian Münz, Anita Murer, Ana Raykova, Obinna Chijioke, Donal McHugh, John M. Ong’echa, Catherine Forconi, Michelle Böni
Jazyk: angličtina
Rok vydání: 2021
Předmět:
0301 basic medicine
Human cytomegalovirus
Epstein-Barr Virus Infections
humanized mouse model
QH301-705.5
viruses
Cell
chemical and pharmacologic phenomena
KSHV
Biology
CD38
medicine.disease_cause
Kaposi sarcoma-associated herpesvirus
General Biochemistry
Genetics and Molecular Biology

Virus
Natural killer cell differentiation
Mice
03 medical and health sciences
0302 clinical medicine
EBV
hemic and lymphatic diseases
medicine
Animals
Humans
Cytotoxic T cell
Epstein-Barr virus
Biology (General)
natural killer cells
virus diseases
Cell Differentiation
biochemical phenomena
metabolism
and nutrition

medicine.disease
Virology
Epstein–Barr virus
Killer Cells
Natural

030104 developmental biology
medicine.anatomical_structure
Herpesvirus 8
Human

Primary effusion lymphoma
030217 neurology & neurosurgery
Zdroj: Cell Reports, Vol 35, Iss 5, Pp 109056-(2021)
ISSN: 2211-1247
Popis: Summary Herpesvirus infections shape the human natural killer (NK) cell compartment. While Epstein-Barr virus (EBV) expands immature NKG2A+ NK cells, human cytomegalovirus (CMV) drives accumulation of adaptive NKG2C+ NK cells. Kaposi sarcoma-associated herpesvirus (KSHV) is a close relative of EBV, and both are associated with lymphomas, including primary effusion lymphoma (PEL), which nearly always harbors both viruses. In this study, KSHV dual infection of mice with reconstituted human immune system components leads to the accumulation of CD56–CD16+CD38+CXCR6+ NK cells. CD56–CD16+ NK cells were also more frequently found in KSHV-seropositive Kenyan children. This NK cell subset is poorly cytotoxic against otherwise-NK-cell-susceptible and antibody-opsonized targets. Accordingly, NK cell depletion does not significantly alter KSHV infection in humanized mice. These data suggest that KSHV might escape NK-cell-mediated immune control by driving CD56–CD16+ NK cell differentiation.
Databáze: OpenAIRE